JP2906236B2 - ビシクロ化合物 - Google Patents

ビシクロ化合物

Info

Publication number
JP2906236B2
JP2906236B2 JP4060887A JP6088792A JP2906236B2 JP 2906236 B2 JP2906236 B2 JP 2906236B2 JP 4060887 A JP4060887 A JP 4060887A JP 6088792 A JP6088792 A JP 6088792A JP 2906236 B2 JP2906236 B2 JP 2906236B2
Authority
JP
Japan
Prior art keywords
group
lower alkyl
dithia
oxo
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP4060887A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05213961A (ja
Inventor
四郎 三田
洋一 河嶋
健一 藤村
寛 須原
全泰 岡本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP4060887A priority Critical patent/JP2906236B2/ja
Priority to US08/005,611 priority patent/US5350860A/en
Priority to ES93300520T priority patent/ES2049712T1/es
Priority to DE93300520T priority patent/DE554032T1/de
Priority to EP93300520A priority patent/EP0554032B1/en
Priority to DE69326173T priority patent/DE69326173T2/de
Publication of JPH05213961A publication Critical patent/JPH05213961A/ja
Priority to GR940300002T priority patent/GR940300002T1/el
Application granted granted Critical
Publication of JP2906236B2 publication Critical patent/JP2906236B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
JP4060887A 1992-01-31 1992-01-31 ビシクロ化合物 Expired - Fee Related JP2906236B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP4060887A JP2906236B2 (ja) 1992-01-31 1992-01-31 ビシクロ化合物
US08/005,611 US5350860A (en) 1992-01-31 1993-01-19 Bicyclic compounds
DE93300520T DE554032T1 (de) 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten.
EP93300520A EP0554032B1 (en) 1992-01-31 1993-01-25 Bicyclic suflur-containing compounds for the treatment of diseases coursed by immune system disorders compounds
ES93300520T ES2049712T1 (es) 1992-01-31 1993-01-25 Un metodo para producir una composicion farmaceutica.
DE69326173T DE69326173T2 (de) 1992-01-31 1993-01-25 Schwefel enthaltende bizyklische Verbindungen zur Behandlung von durch Immunsystemstörungen verursachte Krankheiten
GR940300002T GR940300002T1 (2) 1992-01-31 1994-02-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4060887A JP2906236B2 (ja) 1992-01-31 1992-01-31 ビシクロ化合物

Publications (2)

Publication Number Publication Date
JPH05213961A JPH05213961A (ja) 1993-08-24
JP2906236B2 true JP2906236B2 (ja) 1999-06-14

Family

ID=13155329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4060887A Expired - Fee Related JP2906236B2 (ja) 1992-01-31 1992-01-31 ビシクロ化合物

Country Status (6)

Country Link
US (1) US5350860A (2)
EP (1) EP0554032B1 (2)
JP (1) JP2906236B2 (2)
DE (2) DE554032T1 (2)
ES (1) ES2049712T1 (2)
GR (1) GR940300002T1 (2)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012129A1 (fr) * 1991-01-10 1992-07-23 Santen Pharmaceutical Co., Ltd. Compose cyclique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058973A (ja) * 1983-09-13 1985-04-05 Mitsubishi Yuka Yakuhin Kk γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤
WO1992012129A1 (fr) * 1991-01-10 1992-07-23 Santen Pharmaceutical Co., Ltd. Compose cyclique

Also Published As

Publication number Publication date
JPH05213961A (ja) 1993-08-24
US5350860A (en) 1994-09-27
ES2049712T1 (es) 1994-05-01
GR940300002T1 (2) 1994-02-28
EP0554032A3 (en) 1993-08-18
DE69326173D1 (de) 1999-10-07
EP0554032A2 (en) 1993-08-04
EP0554032B1 (en) 1999-09-01
DE554032T1 (de) 1994-02-24
DE69326173T2 (de) 2000-03-09

Similar Documents

Publication Publication Date Title
DE69524114T2 (de) Naphthyridinonderivate
AU602546B2 (en) Pyridazodiazepine derivatives
KR970701719A (ko) 헤테로고리화합물과 그것의 제법 및 사용(heterocyclic compounds, their preparation and use)
US4639454A (en) Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
PT1369419E (pt) Composto de n-fenilarilsulfonamida, fármaco contendo o composto como ingrediente activo, produtos intermédios para a produção do composto e processos para a produção do composto
EP0039086B1 (en) Novel ampicillin esters and production thereof
JP2906236B2 (ja) ビシクロ化合物
WO1990002129A1 (en) Bivalent ligands effective for blocking acat enzyme
JPS6372660A (ja) 抗高コレステロール血症化合物のプロドラッグ
US4181659A (en) Bis-penicillanoyloxy-alkanes
EP0060081B1 (en) Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them
JP3178070B2 (ja) ラクトンおよびラクタム化合物
JPH01308227A (ja) プロテアーゼ阻害剤
JP3169144B2 (ja) シクロペンタン誘導体
US3635971A (en) 3 (3 4-dihydro-3-oxo-2-quinoxalinyl) propionamides
JP3157341B2 (ja) テトラヒドロチオピラン誘導体
EP0784623A1 (en) Naphthyridine derivatives
US3951957A (en) Chloromethyl ester of penicillins
SU1436877A3 (ru) Способ получени производных эрголина или их фармакологически приемлемых солей
KR790000981B1 (ko) N-(메톡시메틸-푸릴메틸)-6,7-벤조모르판 및 모르피난의 제조방법
US4279910A (en) Quinazoline therapeutic agents
JP2926168B2 (ja) 含硫黄化合物
EP0159692A2 (en) Annulated 4H-1,4-benzothiazine derivatives
AU631801C (en) Bivalent ligands effective for blocking acat enzyme
KR830001902B1 (ko) 폐니실란산유도체의 제조방법

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees